- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Fusion Wins Three Year Contract Worth US$1.1 Million
Fusion (NASDAQ:FSNN) announced that it has won a US$1.1 million three year cloud solutions agreement with a major manufacturer, distributor of healthcare and beauty products. The company said that it would provide its UCaas, SD-WAN and Security Solutions to its new client. As quoted in the press release: The healthcare company was looking to replace …
Fusion (NASDAQ:FSNN) announced that it has won a US$1.1 million three year cloud solutions agreement with a major manufacturer, distributor of healthcare and beauty products.
The company said that it would provide its UCaas, SD-WAN and Security Solutions to its new client.
As quoted in the press release:
The healthcare company was looking to replace and consolidate its legacy network and communications platform with a single vendor, and chose Fusion’s single source cloud solution to drive efficiencies in IT management and cost, while eliminating the time-consuming and resource-wasting finger-pointing that so often occurs in multi-vendor environments. The company further cited Fusion’s comprehensive and fully integrated cloud communications and connectivity solutions, its live, U.S.-based support and user training, and its dedicated account management team for its selection.
Fusion’s cloud-based UCaaS solution will enable the company to provide its employees with multiple collaboration tools, increasing productivity across the enterprise while reducing costs and driving efficiencies in management and support. The company was able to replace several diverse systems as well as costly hardware that was nearing end of life with Fusion’s seamless cloud communications solution. The company also selected Fusion’s award-winning Software-Defined Wide Area Network (SD-WAN), which delivers the always-on, reliable connectivity required to realize the full potential of the cloud. Fusion’s Unified Threat Management solution was selected to deliver the results-oriented security demanded by the company’s rigorous compliance requirements.
“This leading provider of name brand health, wellness and beauty products is justly proud of its reputation for innovation and quality and celebrates the passion of its people for differentiating it within the pharmaceutical industry. We are honored to have been cited for similar service excellence and for the experience and expertise of our technology professionals,” said Dan Foster, Fusion’s Chief Revenue Officer. “The company recognized Fusion for our ability to deliver simple solutions to complex communications challenges by delivering so much more than a few single products, but rather a fully integrated solution that securely and reliably delivers all the productivity and efficiency benefits of the cloud.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.